VASCULOX INC has a total of 13 patent applications. Its first patent ever was published in 2013. It filed its patents most often in United States, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are JUNG GUNDRAM, BIO TECHNOLOGY GENERAL ISRAEL and PEPHARM R & D LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Brazil | 1 | |
#3 | Canada | 1 | |
#4 | Hong Kong | 1 | |
#5 | Israel | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 | |
#8 | Philippines | 1 | |
#9 | Singapore | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Manning Pamela T | 11 |
#2 | Frazier William A | 11 |
#3 | Frey Gerhard | 10 |
#4 | Chang Hwai Wen | 10 |
#5 | Gerhard Frey | 2 |
#6 | William A Frazier | 1 |
#7 | Wen Chang Hwai | 1 |
#8 | Hwai Wen Chang | 1 |
#9 | Pamela T Manning | 1 |
Publication | Filing date | Title |
---|---|---|
US2014161799A1 | Therapeutic CD47 antibodies | |
SG11201504469XA | Therapeutic cd47 antibodies |